100 million doses of Sinopharm’s COVID-19 vaccines supplied worldwide

Share on facebook
Share on twitter
Share on email
Spread the love

A Sinopharm affiliate said on Friday that the two COVID-19 vaccines developed by China National Pharmaceutical Group (Sinopharm) subsidiaries have hit a combined 100 million doses of supply worldwide. 

According to China National Biotec Group Company (CNBG), over 80 million doses of the two vaccines were administered.

An annual capacity of 1 billion jabs could be reached in 2021 and Sinopharm aims to expand capacity to 3 billion doses per year, without specifying the timeframe for the target.

On Monday, another Chinese vaccine maker Sinovac Biotech said it had supplied 160 million doses of its COVID-19 vaccine to 18 countries and regions, including China, with over 70 million shots injected.

Including the vaccine from CanSino Biologics Inc, a total of 4 vaccines have been approved in China for general public use. A fifth vaccine developed by the Institute of Microbiology Chinese Academy of Sciences has gained clearance for limited emergency use.

WHO: Monkeypox to be renamed mpox

Spread the love

Spread the loveGENEVA – Monkeypox is to be renamed mpox in English, the World Health Organization (WHO) said Monday, in a bid to avoid

LATEST NEWS

TRENDING NEWS